Emulate
Emulate Bio is dedicated to advancing human health through innovative organ-on-a-chip technology. They develop microphysiological systems that mimic human organ functions, enabling more accurate disease modeling, drug testing, and therapeutic development. Their mission is to leverage human biology and technology to create a new era in health, reducing reliance on animal models and improving clinical translation.
Industries
Nr. of Employees
medium (51-250)
Emulate
Boston, Massachusetts, United States, North America
Patents
Method of osteogenic differentiation in microfluidic tissue culture systems
US-12070746-B2
View Details
Method of osteogenic differentiation in microfluidic tissue culture systems
US-12070746-B2
View DetailsProducts
High-throughput organ-chip emulation system
An automated platform providing integrated incubation, fluid handling, and imaging to run multiple organ-chip experiments at scale and produce analysis-ready datasets.
Automated culture module for multi-chip incubation (12-chip capacity)
A benchtop culture module that automates fluid flow and environmental control for up to a dozen organ-chip consumables to support model development and validation.
Stretchable two-channel microfluidic organ-chip consumable
A stretchable microfluidic chip consumable with two compartments separated by a porous membrane, supporting cyclic stretch, air–liquid interfaces, and tissue–vascular interfaces.
Accessible gel-compatible organ-chip consumable
A chip consumable with an accessible culture chamber that supports thicker hydrogel scaffolds (up to ~3 mm) and enables topical or aerosolized compound application.
Rigid low-absorption organ-chip consumable for ADME/Tox
A rigid plastic chip consumable engineered to minimize drug absorption, improving compound recovery and quantitative ADME/Tox measurements.
BioKit (pre-qualified cells, consumables, validated protocols)
Turnkey kit bundles that include validated cell lots, consumables, and protocols for specific organ models to accelerate reproducible deployment of organ-chip experiments.
High-throughput organ-chip emulation system
An automated platform providing integrated incubation, fluid handling, and imaging to run multiple organ-chip experiments at scale and produce analysis-ready datasets.
Automated culture module for multi-chip incubation (12-chip capacity)
A benchtop culture module that automates fluid flow and environmental control for up to a dozen organ-chip consumables to support model development and validation.
Stretchable two-channel microfluidic organ-chip consumable
A stretchable microfluidic chip consumable with two compartments separated by a porous membrane, supporting cyclic stretch, air–liquid interfaces, and tissue–vascular interfaces.
Accessible gel-compatible organ-chip consumable
A chip consumable with an accessible culture chamber that supports thicker hydrogel scaffolds (up to ~3 mm) and enables topical or aerosolized compound application.
Rigid low-absorption organ-chip consumable for ADME/Tox
A rigid plastic chip consumable engineered to minimize drug absorption, improving compound recovery and quantitative ADME/Tox measurements.
BioKit (pre-qualified cells, consumables, validated protocols)
Turnkey kit bundles that include validated cell lots, consumables, and protocols for specific organ models to accelerate reproducible deployment of organ-chip experiments.
Services
Onboarding, experimental design advice, and hands-on support from field scientists to develop, qualify, and deploy organ-chip models using customer or supplied cells.
Provision of on-demand webinars, technical notes, data sheets, and curated publication digests that document model performance and use cases.
Commercial engagement to select appropriate organ-chip platforms, consumables, and kits, plus post-sale technical support.
Onboarding, experimental design advice, and hands-on support from field scientists to develop, qualify, and deploy organ-chip models using customer or supplied cells.
Provision of on-demand webinars, technical notes, data sheets, and curated publication digests that document model performance and use cases.
Commercial engagement to select appropriate organ-chip platforms, consumables, and kits, plus post-sale technical support.
Expertise Areas
- Organ-on-a-chip (microphysiological systems) development
- Predictive toxicology and ADME testing
- Immuno-oncology preclinical modeling
- Neurovascular and brain disease modeling
Key Technologies
- Microfluidics (two-channel compartment chips)
- Cyclic mechanical stretch systems
- Air–liquid interface culture
- Vascularized co-culture platforms
News & Updates
Event discussing alternatives to animal testing and Emulate's role in advancing organ-on-a-chip technology.
Webinar on modeling neurological diseases with organ-on-a-chip and iPSC technology.
Conference highlighting the latest research and developments in microphysiological systems.
Summary of the key highlights and research advancements presented at the 2025 MPS World Summit.
A review of the most impactful publications in organ-on-a-chip research in 2024.
A landmark study demonstrating the Liver-Chip's ability to predict drug-induced liver injury better than traditional models.
Event discussing alternatives to animal testing and Emulate's role in advancing organ-on-a-chip technology.
Webinar on modeling neurological diseases with organ-on-a-chip and iPSC technology.
Conference highlighting the latest research and developments in microphysiological systems.
Summary of the key highlights and research advancements presented at the 2025 MPS World Summit.
A review of the most impactful publications in organ-on-a-chip research in 2024.
A landmark study demonstrating the Liver-Chip's ability to predict drug-induced liver injury better than traditional models.